![](https://unicorn-nest.com/wp-content/uploads/2021/11/Aperture-Venture-Partners.jpg?x55332)
Aperture Venture Partners appeared to be the VC, which was created in 2002. The venture was found in North America in United States. The main department of described VC is located in the New York.
This organization was formed by Eric H. Sillman. Besides them, we counted 3 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Aperture Venture Partners, startups are often financed by Lumira Ventures, TPG Biotech, Vivo Capital. The meaningful sponsors for the fund in investment in the same round are Third Point Ventures, Vivo Capital, Lumira Ventures. In the next rounds fund is usually obtained by Third Point Ventures, OrbiMed, Ziegler Meditech Equity Partners.
Opposing the other organizations, this Aperture Venture Partners works on 17 percentage points more the average amount of lead investments. The increased amount of exits for fund were in 2015. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity.
The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight MAKO Surgical, Cardiac Dimensions, Channel Medsystems. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Food and Beverage, Therapeutics.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Miach Orthopaedics | $20M | 02 Apr 2024 | Boston, Massachusetts, United States | ||
XII Medical | $30M | 05 May 2022 | Union City, California, United States | ||
V-Wave | $98M | 16 Dec 2021 | Israel, North District, Israel | ||
PetDx | $62M | 09 Dec 2021 | San Diego, California, United States | ||
Cortica | $60M | 29 Jun 2021 | San Diego, California, United States | ||
Neuros Medical | $38M | 07 Jan 2021 | Ohio, United States | ||
Cardiac Dimensions | $17M | 29 Sep 2020 | Washington, United States | ||
V-Wave | $28M | 22 Sep 2020 | Israel, North District, Israel | ||
Tarsus Pharmaceuticals | $60M | 08 Jan 2020 | Irvine, California, United States |
– Cortica from San Diego CA is focused on clinical services for autism and other neurodevelopmental conditions.
– Series C $60m funding round was led by Longitude Capital with participation from 406 Ventures, Adam Boehler, Questa Capital and Aperture Venture Partners and Silicon Valley Bank.
– The new financing will be used to accelerate growth, expand centers across multiple states, and investigate novel drug, device, and diagnostic technologies through sponsored and NIH-funded research.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Miach Orthopaedics | $20M | 02 Apr 2024 | Boston, Massachusetts, United States | ||
XII Medical | $30M | 05 May 2022 | Union City, California, United States | ||
V-Wave | $98M | 16 Dec 2021 | Israel, North District, Israel | ||
PetDx | $62M | 09 Dec 2021 | San Diego, California, United States | ||
Cortica | $60M | 29 Jun 2021 | San Diego, California, United States | ||
Neuros Medical | $38M | 07 Jan 2021 | Ohio, United States | ||
Cardiac Dimensions | $17M | 29 Sep 2020 | Washington, United States | ||
V-Wave | $28M | 22 Sep 2020 | Israel, North District, Israel | ||
Tarsus Pharmaceuticals | $60M | 08 Jan 2020 | Irvine, California, United States |